iShares Neuroscience and Healthcare ETF
Limited financial coverage for IBRN.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U. S.
- IPO
- 2022
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on IBRN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.07M
- Div Yield
- 1.01%
- 52W High
- $43.01
- 52W Low
- $27.40
- 50D MA
- $37.05
- 200D MA
- $34.86
- Beta
- 0.87
- RSI (14)
- 18
- Avg Volume
- 2.76K
No earnings-call transcripts are available for IBRN yet.
- Free Float
- 0.0%
- Shares Outstanding
- 159.32K
- Float Shares
- 0
Our IBRN coverage
Recent articles, reports, and earnings notes.
No research on IBRN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBRN report →FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
zacks.com · Aug 27
These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022
etftrends.com · Oct 3
4 Best ETF Areas of Last Week That Are Up At Least 5%
zacks.com · Oct 3
Why Now Could Be The Time To Consider Neuroscience Investments
seekingalpha.com · Aug 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.